Results 81 to 90 of about 96,047 (253)
Safety and prognostic value of left ventricular endomyocardial biopsy in dilated cardiomyopathy
Safety and prognostic value of left ventricular endomyocardial biopsy in dilated cardiomyopathy. CVF, left ventricular collagen volume fraction; DCM, dilated cardiomyopathy; EMB, endomyocardial biopsy; LV, left ventricular. Aims The need to perform endomyocardial biopsy (EMB) in patients with non‐ischaemic dilated cardiomyopathies (DCM) is debated ...
Elham Kayvanpour +15 more
wiley +1 more source
The role of immune mechanisms in hypertension and advances in immunomodulatory research
Hypertension is one of the major risk factors for cardiovascular diseases and end-organ damage worldwide. Traditionally, it has been linked to factors such as genetics, diet, and lifestyle.
XiaoLi Chen +3 more
doaj +1 more source
Aims Mineralocorticoid receptor antagonists (MRAs) are often underused in patients with heart failure (HF) and reduced ejection fraction (HFrEF). Individual treatment effect (ITE) may assist physicians in making timely decisions about which patients are the best suited for personalized therapy.
Masatake Kobayashi +9 more
wiley +1 more source
Predictive use of routine 24-hour electrocardiography in suspected Adams-Stokes syndrome. Comparison with cardiac rhythm during symptoms. [PDF]
Nils‐Johan Abdon +2 more
openalex +1 more source
Takotsubo cardiomyopathy during armed conflict: A case series
ESC Heart Failure, Volume 12, Issue 2, Page 1494-1498, April 2025.
Sharon Bruoha +13 more
wiley +1 more source
Longest survivor of pulmonary atresia with ventricular septal defect without surgical intervention
ESC Heart Failure, Volume 12, Issue 2, Page 1499-1507, April 2025.
Sang Zhou +5 more
wiley +1 more source
Heart failure in two male patients with late‐onset Fabry mutation (IVS4 + 919G > A)
ESC Heart Failure, Volume 12, Issue 2, Page 1508-1513, April 2025.
Xufei Yang +3 more
wiley +1 more source
Background Gastric cancer (GC) has poor prognosis due to distant metastasis with ovarian metastasis (OM) occurring in 5–10% of female patients and survival limited to 7–14 months. No standard treatment exists.
Liping Wang +3 more
doaj +1 more source

